These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 601798)

  • 41. Effect of silybin on the hepatic microsomal drug-metabolising enzyme system in the rat.
    Down WH; Chasseaud LF; Grundy RK
    Arzneimittelforschung; 1974 Dec; 24(12):1986-8. PubMed ID: 4218108
    [No Abstract]   [Full Text] [Related]  

  • 42. The liver microsomal hydroxylation enzyme system. Induction and properties of the functional components.
    Lu AY; Kuntzman R; Conney AH
    Front Gastrointest Res; 1976; 2():1-31. PubMed ID: 819342
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of underfeeding suckling rats on the activity of hepatic drug metabolizing enzymes.
    Basu TK; Dickerson JW; Parke DV
    Biol Neonate; 1973; 23(1):109-15. PubMed ID: 4773512
    [No Abstract]   [Full Text] [Related]  

  • 44. The relative ethylumbelliferone dealkylase activity characterizing the effect of different inducers on the hydroxylase system in the liver microsomes of female mice.
    Mohn G; Niederlaender P; Kessler C
    Biochem Pharmacol; 1977 Oct; 26(20):1885-92. PubMed ID: 911342
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of alteration of rat hepatic mixed-function oxidase (MFO) activity on the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Beatty PW; Vaughn WK; Neal RA
    Toxicol Appl Pharmacol; 1978 Aug; 45(2):513-9. PubMed ID: 705787
    [No Abstract]   [Full Text] [Related]  

  • 46. Constitutive and induced hepatic microsomal cytochrome P-450 monooxygenase activities in male Fischer-344 and CD rats. A comparative study.
    Dent JG; Graichen ME; Schnell S; Lasker J
    Toxicol Appl Pharmacol; 1980 Jan; 52(1):45-53. PubMed ID: 6767296
    [No Abstract]   [Full Text] [Related]  

  • 47. Decreased effect of phenobarbital treatment on microsomal drug metabolizing enzyme activity during gestation.
    Schlede E; Borowski R
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(4):341-55. PubMed ID: 4275256
    [No Abstract]   [Full Text] [Related]  

  • 48. A possible protective role for reduced glutathione in aflatoxin B1 toxicity: effect of pretreatment of rats with phenobarbital and 3-methylcholanthrene on aflatoxin toxicity.
    Mgbodile MU; Holscher M; Neal RA
    Toxicol Appl Pharmacol; 1975 Oct; 34(1):128-42. PubMed ID: 1198610
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies of the microsomal drug metabolism system in warfarin-resistant and -susceptible rats.
    Townsend MG; Odam EM; Page JM
    Biochem Pharmacol; 1975 Mar; 24(6):729-35. PubMed ID: 1125075
    [No Abstract]   [Full Text] [Related]  

  • 50. Ethoxyquin as an inducer and inhibitor of phenobarbital-type cytochrome P-450 in rat liver microsomes.
    Kahl R; Netter KJ
    Toxicol Appl Pharmacol; 1977 Jun; 40(3):473-83. PubMed ID: 882982
    [No Abstract]   [Full Text] [Related]  

  • 51. A comparison of the inductive effects of phenobarbital, methaqualone, and methyprylon on hepatic mixed function oxidase enzymes in the rat.
    Reinke LA; O'Connor MF; Piepho RW; Stohs SJ
    Res Commun Chem Pathol Pharmacol; 1975 May; 11(1):45-53. PubMed ID: 239443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential oxidase activity of hepatic and pulmonary microsomal cytochrome P-450 isozymes after treatment with cytochrome P-450 inducers.
    Sakai H; Park SS; Kikkawa Y
    Biochem Biophys Res Commun; 1992 Sep; 187(3):1262-9. PubMed ID: 1329733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of dibromotetrafluoroethane inhalation on hepatic drug metabolism in mice.
    Murphy JP; Van Stee EW; Back KC
    Biochem Pharmacol; 1973 Nov; 22(22):2843-51. PubMed ID: 4761555
    [No Abstract]   [Full Text] [Related]  

  • 54. Inhibition of hepatic mixed-function oxidase activity in vitro and in vivo by various thiono-sulfur-containing compounds.
    Hunter AL; Neal RA
    Biochem Pharmacol; 1975 Dec; 24(23):2199-205. PubMed ID: 2176
    [No Abstract]   [Full Text] [Related]  

  • 55. [Selective induction of a liver microsomal mixed-function oxygenase system. II. Kinetic study of benz(a)pyrene hydroxylase].
    Roberfroid M; Cumps J; Razzouk C
    Arch Int Physiol Biochim; 1974 Feb; 82(1):199. PubMed ID: 4136435
    [No Abstract]   [Full Text] [Related]  

  • 56. Cytochrome P-450 linked mixed function oxidase turnover of microsomal components and effects of inducers on the turnover phospholipids, proteins and specific enzymes.
    Omura T
    Pharmacol Ther; 1980; 8(3):489-99. PubMed ID: 6770378
    [No Abstract]   [Full Text] [Related]  

  • 57. Activities of hepatic and extrahepatic microsomal mixed function oxidase enzymes in diabetic and gonadectomized-diabetic rats.
    Al-Turk WA; Stohs SJ; Roche EB
    Gen Pharmacol; 1981; 12(5):345-50. PubMed ID: 7286602
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of rifampicin on the mouse hepatic mixed-function oxidase system.
    Tredger JM; Smith HM; Powell-Jackson PR; Davis M; Williams R
    Biochem Pharmacol; 1981 May; 30(10):1043-51. PubMed ID: 6789832
    [No Abstract]   [Full Text] [Related]  

  • 59. Sex-related differences in drug metabolism.
    Kato R
    Drug Metab Rev; 1974; 3(1):1-32. PubMed ID: 4154185
    [No Abstract]   [Full Text] [Related]  

  • 60. Induction of cytochrome P-450 isozymes by chromanamine derivatives in rat liver.
    Tsukidate K; Sagami F; Horie T; Fukuda T; Kitada M; Kanakubo Y
    Xenobiotica; 1989 Aug; 19(8):901-12. PubMed ID: 2815832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.